National Rosacea Society awards research grants

The National Rosacea Society has awarded funding to three new and two ongoing studies, according to a press release.

“Research supported by [National Rosacea Society (NRS)] has led to important insights into the physiology of the disorder, providing an essential foundation for developing new and better treatments,” Martin Steinhoff, MD, MSc, PhD, chairman of dermatology and director of Charles Institute of Dermatology, University College, Dublin, and a member of the NRS Medical Advisory Board, which selects research proposals for funding, stated in the release. “In addition, our growing knowledge is now pointing toward potentially meaningful connections between rosacea and other systemic illnesses.”

The following $25,000 grants awarded, according to the release:

Luis Garza, MD, PhD, associate professor of dermatology at Johns Hopkins University, and colleagues, for a study on epigenetic lesions in rosacea.

Wenqing Li, MD, PhD, assistant professor of dermatology, Brown University, to clarify how hormone use and hormone levels associated with menopause and during pregnancy may affect the risk of developing rosacea.

Anna Di Nardo, MD, PhD, and colleagues, in their research to determine whether the release of cathelicidin antimicrobial peptides is central to the connection between the nervous system and skin inflammation through the activation of mast cells in rosacea.

Funding also was granted to continued studies by Gideon Smith, MD, PhD, assistant physician in dermatology at Massachusetts General Hospital and instructor at Harvard University and colleagues, for an investigation of rosacea and the vascular system, and Lori Lee Stohl, PhD, research associate, Weill Cornell Medical School, for her research on biochemicals released during stress and a possible association to rosacea, according to the release.

Reference: www.rosacea.org